Despite these suggestive mechanisms, systematic clinical evaluations of serum GPR‐120 levels in DN remain limited, leaving critical questions about its association with key markers, such as cystatin C, estimated glomerular filtration rate (eGFR), and microalbuminuria, unanswered. The gene discussed is CST3; the disease is liver dysplastic nodule.